Niclosamide
-
Catalog number1826-500
-
PricePlease ask
-
Size500 mg
-
-
Alternative_name5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide
-
DescriptionA STAT3 signaling pathway inhibitor. Niclosamide potently inhibits the activation and transcriptional function of STAT3 and induces cell growth inhibition, apoptosis, and cell cycle arrest of cancer cells with constitutively active STAT3. Also reversibly inhibits mTORC1 signaling and stimulates autophagy in vitro; displays antineoplastic effects in acute myelogenous leukemia (AML) stem cells.
-
CAS Number50-65-7
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₃H₈Cl₂N₂O₄
-
Molecular Weight327.12
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (10 mM) or Ethanol (25 mM)
-
HandlingProtect from air and light
-
Tag LineA STAT3 signaling pathway inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD00057597
-
PubChem CID4477
-
SMILESC1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O
-
InChiInChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)
-
InChi KeyRJMUSRYZPJIFPJ-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameNiclosamide
-
Alternative nameNiclosamide
-